Hybrid ablation of persistent and long-standing persistent atrial fibrillation with depressed ejection fraction: A single-center observational study

Selection of patients for hybrid ablation procedure

“…Kiankhooy et al used a thoracoscopic hybrid approach for patients with depressed EF and tachycardia-mediated cardiomyopathy, which demonstrated feasibility and significantly improved ejection fraction after treatment at a mean of 3.5 years (±1.9 years) follow-up and improvement in NYHA Class from baseline. 40…”

“…Our multicenter retrospective analysis of patients included those presenting with severely reduced baseline LVEF (≤40%) and showed significantly improved LVEF after Hybrid Convergent treatment. Kiankhooy et al used a thoracoscopic hybrid approach for patients with depressed EF and tachycardia‐mediated cardiomyopathy, which demonstrated feasibility and significantly improved ejection fraction after treatment at a mean of 3.5 years (±1.9 years) follow‐up and improvement in NYHA Class from baseline 40 …”

Selection of Patients for Hybrid Ablation Procedure

“…Kiankhooy et al used a thoracoscopic hybrid approach for patients with depressed EF and tachycardia mediated cardiomyopathy, which demonstrated feasibility and significantly improved ejection fraction after treatment at a mean of 3.5 years (±1.9 years) follow-up and improvement in NYHA Class from baseline. 37 Left Atrial Appendage (LAA)/Ligament of Marshall As previously discussed, patients with advanced AF have more non-pulmonary vein triggers, such as the posterior wall, and this can also include the LAA and Ligament of Marshall (LOM). 38 Excluding the LAA at the time of the hybrid epicardial ablation stage can address a site of AF triggers through electrical isolation as well eliminating a predominant site of thrombus in AF.…”